A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 26, 2019

Primary Completion Date

May 17, 2023

Study Completion Date

May 17, 2023

Conditions

Neoplasm

Interventions

DRUG

BI 891065

film-coated tablets

Trial Locations (1)

National Cancer Center Hospital, Tokyo, Chuo-ku